Ascopiave Balance Sheet Health

Financial Health criteria checks 1/6

Ascopiave has a total shareholder equity of €854.3M and total debt of €438.8M, which brings its debt-to-equity ratio to 51.4%. Its total assets and total liabilities are €1.5B and €607.7M respectively. Ascopiave's EBIT is €52.4M making its interest coverage ratio 10.3. It has cash and short-term investments of €54.2M.

Key information

51.4%

Debt to equity ratio

€438.76m

Debt

Interest coverage ratio10.3x
Cash€54.16m
Equity€854.28m
Total liabilities€607.70m
Total assets€1.46b

Recent financial health updates

Recent updates

Ascopiave's (BIT:ASC) Earnings Offer More Than Meets The Eye

Apr 07
Ascopiave's (BIT:ASC) Earnings Offer More Than Meets The Eye

Ascopiave's (BIT:ASC) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 13
Ascopiave's (BIT:ASC) Shareholders Will Receive A Bigger Dividend Than Last Year

Ascopiave (BIT:ASC) Takes On Some Risk With Its Use Of Debt

Mar 08
Ascopiave (BIT:ASC) Takes On Some Risk With Its Use Of Debt

Ascopiave (BIT:ASC) Is Paying Out Less In Dividends Than Last Year

Mar 11
Ascopiave (BIT:ASC) Is Paying Out Less In Dividends Than Last Year

Ascopiave S.p.A.'s (BIT:ASC) Intrinsic Value Is Potentially 50% Above Its Share Price

Oct 20
Ascopiave S.p.A.'s (BIT:ASC) Intrinsic Value Is Potentially 50% Above Its Share Price

Here's Why Ascopiave (BIT:ASC) Has A Meaningful Debt Burden

Sep 26
Here's Why Ascopiave (BIT:ASC) Has A Meaningful Debt Burden

Need To Know: The Consensus Just Cut Its Ascopiave S.p.A. (BIT:ASC) Estimates For 2022

Aug 12
Need To Know: The Consensus Just Cut Its Ascopiave S.p.A. (BIT:ASC) Estimates For 2022

Investors Could Be Concerned With Ascopiave's (BIT:ASC) Returns On Capital

Jun 14
Investors Could Be Concerned With Ascopiave's (BIT:ASC) Returns On Capital

What Does Ascopiave S.p.A.'s (BIT:ASC) Share Price Indicate?

Mar 05
What Does Ascopiave S.p.A.'s (BIT:ASC) Share Price Indicate?

Ascopiave (BIT:ASC) May Have Issues Allocating Its Capital

Oct 25
Ascopiave (BIT:ASC) May Have Issues Allocating Its Capital

Ascopiave (BIT:ASC) Might Be Having Difficulty Using Its Capital Effectively

Jul 20
Ascopiave (BIT:ASC) Might Be Having Difficulty Using Its Capital Effectively

At €3.73, Is It Time To Put Ascopiave S.p.A. (BIT:ASC) On Your Watch List?

Jun 06
At €3.73, Is It Time To Put Ascopiave S.p.A. (BIT:ASC) On Your Watch List?

Something To Consider Before Buying Ascopiave S.p.A. (BIT:ASC) For The 4.1% Dividend

Apr 13
Something To Consider Before Buying Ascopiave S.p.A. (BIT:ASC) For The 4.1% Dividend

Ascopiave (BIT:ASC) Seems To Use Debt Quite Sensibly

Mar 28
Ascopiave (BIT:ASC) Seems To Use Debt Quite Sensibly

Ascopiave S.p.A. Just Beat EPS By 56%: Here's What Analysts Think Will Happen Next

Mar 14
Ascopiave S.p.A. Just Beat EPS By 56%: Here's What Analysts Think Will Happen Next

Here's What To Make Of Ascopiave's (BIT:ASC) Returns On Capital

Mar 01
Here's What To Make Of Ascopiave's (BIT:ASC) Returns On Capital

At €3.76, Is Ascopiave S.p.A. (BIT:ASC) Worth Looking At Closely?

Feb 15
At €3.76, Is Ascopiave S.p.A. (BIT:ASC) Worth Looking At Closely?

Can Ascopiave S.p.A.'s (BIT:ASC) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Feb 02
Can Ascopiave S.p.A.'s (BIT:ASC) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Shareholders Of Ascopiave (BIT:ASC) Must Be Happy With Their 134% Total Return

Jan 18
Shareholders Of Ascopiave (BIT:ASC) Must Be Happy With Their 134% Total Return

Consider This Before Buying Ascopiave S.p.A. (BIT:ASC) For The 5.9% Dividend

Jan 03
Consider This Before Buying Ascopiave S.p.A. (BIT:ASC) For The 5.9% Dividend

Does Ascopiave's (BIT:ASC) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 19
Does Ascopiave's (BIT:ASC) Statutory Profit Adequately Reflect Its Underlying Profit?

How Much Of Ascopiave S.p.A. (BIT:ASC) Do Institutions Own?

Dec 05
How Much Of Ascopiave S.p.A. (BIT:ASC) Do Institutions Own?

Does Ascopiave (BIT:ASC) Have A Healthy Balance Sheet?

Nov 19
Does Ascopiave (BIT:ASC) Have A Healthy Balance Sheet?

Financial Position Analysis

Short Term Liabilities: ASC's short term assets (€185.2M) do not cover its short term liabilities (€245.8M).

Long Term Liabilities: ASC's short term assets (€185.2M) do not cover its long term liabilities (€361.9M).


Debt to Equity History and Analysis

Debt Level: ASC's net debt to equity ratio (45%) is considered high.

Reducing Debt: ASC's debt to equity ratio has increased from 41.6% to 51.4% over the past 5 years.

Debt Coverage: ASC's debt is not well covered by operating cash flow (1.4%).

Interest Coverage: ASC's interest payments on its debt are well covered by EBIT (10.3x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.